Volume 109, Issue 3 pp. 234-238
Research Article

Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy

Yan-Long Liu MD

Yan-Long Liu MD

Department of Colorectal Surgery, The Affiliated 3rd Hospital of Harbin Medical University, Harbin, PR China

Search for more papers by this author
Hai-tao Xu MD

Hai-tao Xu MD

Department of Hepatobiliary and Pancreatic Surgery, The Affiliated 3rd Hospital of Harbin Medical University, Harbin, PR China

Search for more papers by this author
Shi-Xiong Jiang MD

Shi-Xiong Jiang MD

Department of Colorectal Surgery, The Affiliated 3rd Hospital of Harbin Medical University, Harbin, PR China

Search for more papers by this author
Yan-Mei Yang MD

Yan-Mei Yang MD

Cancer Research Institute, Harbin Medical University, Harbin, PR China

Search for more papers by this author
Bin-Bin Cui MD

Corresponding Author

Bin-Bin Cui MD

Department of Colorectal Surgery, The Affiliated 3rd Hospital of Harbin Medical University, Harbin, PR China

Correspondence to: Bin-Bin Cui, M.D., Department of Colorectal Surgery, The Affiliated 3rd Hospital of Harbin Medical University, 150 Haping Road, Nangang District, Harbin 150040, PR China. Fax: 86-451-86298786.

E-mail: [email protected]

Search for more papers by this author
First published: 21 January 2014
The authors declare no conflicts of interest.
Yan-Long Liu and Hai-tao Xu contributed equally to this study and should be considered co-first authors.
Y.L.L. and H.T.X. developed study design and drafted the manuscript, S.X.J. carried out data acquisition, Y.M.Y. conducted statistical analysis, B.B.C. conceived the study, participated in developing study design, and coordinated the work. All authors read and approved the final manuscript.

Abstract

Background and Objectives

To test prognostic significance of lymph node status in patients with metastatic colorectal carcinoma (mCRC).

Methods

Four hundred ninety six patients diagnosed with synchronous mCRC and treated with lymphadenectomy between 1995 and 2008 were identified and divided into groups pN0, pN1, and pN2 (140 (28.2%) in pN0, 223 (45.0%) in pN1, and 133 (26.8%) in pN2 group) according to their lymph node status. The Kaplan–Meier and Cox regression analyses were used to test associations and independent predictor status of lymph node involvement.

Results

The Cox proportional hazards regression showed pN as significantly associated with disease-specific survival (DSS) both in univariate (HR = 1.609, 95% CI 1.411 to 1.835, P < 0.001) and multivariate (HR = 1.630, 95% CI 1.422 to 1.868, P < 0.001) analyses. The Kaplan–Meier analysis demonstrated that patients with pN2 and pN1 had a significantly worse DSS compared with patients with pN0 tumors (respectively, 17.273 ± 1.020 and 27.145 ± 1.715 vs. 34.992 ± 2.143 months; P < 0.001). In accuracy analyses based on AUC values, nodal status demonstrated the highest accuracy (65.1%) out of all the variables.

Conclusions

Our findings indicate that optimal TNM staging for mCRC should incorporate lymph node status to provide a more effective and predictive model. J. Surg. Oncol. © 2014 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.